Guatemala - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingGuatemala: Vaccine Market 2024
Vaccine Market Size in Guatemala
The Guatemalan vaccine market shrank rapidly to $X in 2022, reducing by -35.8% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption, however, continues to indicate prominent growth. As a result, consumption reached the peak level of $X, and then contracted significantly in the following year.
Vaccine Exports
Exports from Guatemala
In 2022, exports of vaccines for human medicine from Guatemala skyrocketed to X kg, growing by 44% on the previous year. Overall, exports saw a relatively flat trend pattern. The pace of growth appeared the most rapid in 2016 when exports increased by 282% against the previous year. The exports peaked at X kg in 2017; however, from 2018 to 2022, the exports stood at a somewhat lower figure.
In value terms, vaccine exports surged to $X in 2022. Over the period under review, exports saw slight growth. The most prominent rate of growth was recorded in 2013 when exports increased by 277%. The exports peaked at $X in 2016; however, from 2017 to 2022, the exports failed to regain momentum.
Exports by Country
Belize (X kg) was the main destination for vaccine exports from Guatemala, with a 95% share of total exports. Moreover, vaccine exports to Belize exceeded the volume sent to the second major destination, the Dominican Republic (X kg), more than tenfold.
From 2012 to 2022, the average annual growth rate of volume to Belize stood at +22.2%.
In value terms, Belize ($X) remains the key foreign market for vaccines for human medicine exports from Guatemala, comprising 96% of total exports. The second position in the ranking was taken by the Dominican Republic ($X), with a 4.1% share of total exports.
From 2012 to 2022, the average annual growth rate of value to Belize amounted to +21.8%.
Export Prices by Country
The average vaccine export price stood at $X per ton in 2022, which is down by -6.7% against the previous year. Overall, the export price, however, continues to indicate a mild expansion. The pace of growth appeared the most rapid in 2013 an increase of 71% against the previous year. The export price peaked at $X per ton in 2015; however, from 2016 to 2022, the export prices remained at a lower figure.
Average prices varied noticeably for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was Belize ($X per ton), while the average price for exports to the Dominican Republic totaled $X per ton.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to El Salvador (+24.4%), while the prices for the other major destinations experienced more modest paces of growth.
Vaccine Imports
Imports into Guatemala
In 2022, approx. X tons of vaccines for human medicine were imported into Guatemala; declining by -28.7% against the previous year. In general, imports, however, continue to indicate a resilient expansion. The growth pace was the most rapid in 2021 when imports increased by 130% against the previous year. As a result, imports reached the peak of X tons, and then shrank markedly in the following year.
In value terms, vaccine imports reduced rapidly to $X in 2022. Overall, imports, however, recorded a prominent expansion. The pace of growth appeared the most rapid in 2021 with an increase of 345% against the previous year. As a result, imports reached the peak of $X, and then reduced sharply in the following year.
Imports by Country
The United States (X tons), Russia (X tons) and India (X tons) were the main suppliers of vaccine imports to Guatemala, together accounting for 58% of total imports. Belgium, Panama, the Netherlands, Argentina, France and Canada lagged somewhat behind, together accounting for a further 27%.
From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by the Netherlands (with a CAGR of +171.2%), while imports for the other leaders experienced more modest paces of growth.
In value terms, Russia ($X), the United States ($X) and Belgium ($X) constituted the largest vaccine suppliers to Guatemala, with a combined 59% share of total imports. Argentina, the Netherlands, India, Panama, France and Canada lagged somewhat behind, together comprising a further 16%.
The Netherlands, with a CAGR of +230.2%, recorded the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2022, the average vaccine import price amounted to $X per ton, which is down by -14.2% against the previous year. Overall, the import price, however, continues to indicate resilient growth. The pace of growth was the most pronounced in 2021 an increase of 94% against the previous year. As a result, import price attained the peak level of $X per ton, and then reduced in the following year.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Argentina ($X per ton), while the price for India ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Argentina (+25.0%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the vaccine market in Guatemala. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
- Guatemala
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Guatemala
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the vaccine market in Asia.
This report provides an in-depth analysis of the vaccine market in the U.S..
This report provides an in-depth analysis of the vaccine market in China.
This report provides an in-depth analysis of the vaccine market in the EU.
This report provides an in-depth analysis of the global vaccine market.